Kamada (KMDA) Research & Development (2012 - 2026)
Kamada (KMDA) reported Research & Development of $2.2 million for Q1 2026, down 48.63% on a YoY basis from $4.2 million in Q1 2025, and down 24.64% quarter-over-quarter from $2.9 million in Q4 2025.
Kamada (KMDA) Research & Development (2012 - 2026) Analysis & Trends
Kamada has reported Research & Development for 15 years, with the latest figure at $2.2 million in Q1 2026.
- For the quarter ending Q1 2026, Research & Development fell 48.63% year-over-year to $2.2 million; the trailing twelve-month figure through Mar 2026 stood at $7.7 million (down 25.38% YoY), and the FY2025 full-year result was $13.0 million, down 14.42% from the prior year.
- Research & Development for Q1 2026 stood at $2.2 million, down from $2.9 million in the prior quarter.
- The five-year high for Research & Development was $4.4 million in Q1 2022, with the low at $3118.0 in Q3 2022.
- Historically, Research & Development has averaged $2.5 million across 5 years, with a median of $2.9 million in 2025.
- Annual changes were most pronounced in 2023 — Research & Development plunged 99.93% — and 2024, when it surged 132830.98%.
- Kamada's Research & Development stood at $3.0 million in 2022, then climbed by 8.29% to $3.2 million in 2023, then fell by 17.47% to $2.7 million in 2024, then grew by 8.27% to $2.9 million in 2025, then retreated by 24.64% to $2.2 million in 2026.
- The last three Research & Development figures came in at $2.2 million (Q1 2026), $2.9 million (Q4 2025), and $2.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 222.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 180.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 138.20 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 934,363.43 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 296.20 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 97.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 103.35 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 39.38 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 46.94 Mn |
| 10 | Kamada | 505.05 | -73.15 Mn | 19.12 Mn | 2.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.18 Mn |
| Dec 31, 2025 | 2.89 Mn |
| Sep 30, 2025 | 2.64 Mn |
| Jun 30, 2025 | 3,219.00 |
| Mar 31, 2025 | 4.25 Mn |
| Dec 31, 2024 | 2.67 Mn |
| Sep 30, 2024 | 3.41 Mn |
| Jun 30, 2024 | 4,803.00 |
| Mar 31, 2024 | 4.30 Mn |
| Dec 31, 2023 | 3.24 Mn |
| Sep 30, 2023 | 3.18 Mn |
| Jun 30, 2023 | 4.28 Mn |
| Mar 31, 2023 | 3,231.00 |
| Dec 31, 2022 | 2.99 Mn |
| Sep 30, 2022 | 3,118.00 |
| Jun 30, 2022 | 2.64 Mn |
| Mar 31, 2022 | 4.42 Mn |
| Dec 31, 2021 | 3.45 Mn |
| Sep 30, 2021 | 2.55 Mn |
| Jun 30, 2021 | 2.74 Mn |